Gene Expression in Atherosclerotic Lesion of ApoE Deficient Mice

BackgroundAtherosclerosis, the major cause of mortality and invalidity in industrialized countries, is a multi-factorial disease associated with high plasma cholesterol levels and inflammation in the vessel wall. Many different genes have previously been demonstrated in atherosclerosis, although limited numbers of genes are dealt with in each study. In general, data on dynamic gene expression during disease progress is limited and large-scale evaluation of gene expression patterns during atherogenesis could lead to a better understanding of the key events in the pathogenesis of atherosclerosis. We have therefore applied a mouse gene filter array to analyze gene expression in atherosclerotic ApoE-deficient mice.Materials and MethodsApoE-deficient mice were fed atherogenic western diet for 10 or 20 weeks and aortas isolated. C57BL/6 mice on normal chow were used as controls. The mRNAs of 15 animals were pooled and hybridized onto commercially available Clontech mouse gene array filters.ResultsThe overall gene expression in the ApoE-deficient and control mice correlated well at both time points. Gene expression profiling showed varying patterns including genes up-regulated at 10 or 20 weeks only. At 20 weeks of diet, an increasing number of up-regulated genes were found in ApoE-deficient mice.ConclusionsThe gene expression in atherogenesis is not a linear process with a maximal expression at advanced lesion stage. Instead, several genes demonstrate a dynamic expression pattern with peaks at the intermediate lesions stage. Thus, detailed evaluation of gene expression at several time points should help understanding the development of atherosclerosis and establishment of preventive intervention.

[1]  Gerrity Rg The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981 .

[2]  R. Gerrity The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981, The American journal of pathology.

[3]  G. Camejo,et al.  Effect of arterial proteoglycans on the interaction of LDL with human monocyte-derived macrophages. , 1987, Atherosclerosis.

[4]  Kathleen M. Smith,et al.  Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. , 1988, The Journal of clinical investigation.

[5]  G. Hansson,et al.  Detection of activated T lymphocytes in the human atherosclerotic plaque. , 1989, The American journal of pathology.

[6]  G. Bondjers,et al.  Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[7]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[8]  N. Maeda,et al.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Libby,et al.  Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Ross,et al.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[11]  D. Adams,et al.  Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Buriani,et al.  Mast cells synthesize, store, and release nerve growth factor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Skaper,et al.  Nerve growth factor and autoimmune diseases. , 1994, Autoimmunity.

[14]  K. Pavelić [What is molecular medicine?]. , 1994, Lijecnicki vjesnik.

[15]  J. Witztum,et al.  T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Aoki,et al.  Expression of local hepatocyte growth factor system in vascular tissues. , 1995, Biochemical and biophysical research communications.

[17]  P. Bird,et al.  A retinoic acid/cAMP-responsive enhancer containing a cAMP responsive element is required for the activation of the mouse thrombomodulin-encoding gene in differentiating F9 cells. , 1996, Gene.

[18]  C. Alpers,et al.  Platelet-derived growth factor-A mRNA expression in fetal, normal adult, and atherosclerotic human aortas. Analysis by competitive polymerase chain reaction. , 1996, Circulation.

[19]  J. Breslow Mouse Models of Atherosclerosis , 1996, Science.

[20]  M. Cybulsky,et al.  Immunology of atherosclerosis: the promise of mouse models. , 1996, The American journal of pathology.

[21]  B. Johansen,et al.  Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[22]  S. Bonini,et al.  Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. , 1997, The Journal of allergy and clinical immunology.

[23]  E. Braunwald Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.

[24]  W. Jiang,et al.  Regulation of endothelial CD44 expression and endothelium-tumour cell interactions by hepatocyte growth factor/scatter factor. , 1997, Biochemical and biophysical research communications.

[25]  R. Paus,et al.  Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma , 1998, European journal of immunology.

[26]  Y. Nakamura,et al.  Gene expression of neurotrophins and their receptors in cultured rat vascular smooth muscle cells. , 1998, Biochemical and biophysical research communications.

[27]  R. Ross,et al.  Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[28]  P. Libby,et al.  CD40 signaling in vascular cells: a key role in atherosclerosis? , 1998, Atherosclerosis.

[29]  R. Hynes,et al.  The combined role of P- and E-selectins in atherosclerosis. , 1998, The Journal of clinical investigation.

[30]  S. Kunkel Through the looking glass: the diverse in vivo activities of chemokines. , 1999, The Journal of clinical investigation.

[31]  R. Ross Atherosclerosis is an inflammatory disease , 1999 .

[32]  S. Ylä-Herttuala,et al.  Functional genomics and DNA array techniques in atherosclerosis research. , 1999, Current Opinion in Lipidology.

[33]  L. Overbergh,et al.  Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. , 1999, Cytokine.

[34]  L. Devi,et al.  Neurotrophic Factors Regulate Cathepsin S in Macrophages and Microglia: A Role in the Degradation of Myelin Basic Protein and Amyloid β Peptide , 1999, Molecular medicine.

[35]  J. Mesirov,et al.  Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Newby,et al.  Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. , 1999, Cardiovascular research.

[37]  C. Overall,et al.  Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. , 2000, Science.

[38]  T. Yue,et al.  Expression of monocyte chemotactic protein-3 mRNA in rat vascular smooth muscle cells and in carotid artery after balloon angioplasty. , 2000, Biochimica et biophysica acta.

[39]  M. Cybulsky,et al.  High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. , 2000, The Journal of clinical investigation.

[40]  D. Rader,et al.  Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice , 2000, The Journal of Immunology.

[41]  A. Brinkmann,et al.  Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method , 2000, British Journal of Cancer.

[42]  Y. Yuzawa,et al.  Neointima formation in a restenosis model is suppressed in midkine-deficient mice. , 2000, The Journal of clinical investigation.

[43]  A. Togias,et al.  Nerve growth factor expression and release in allergic inflammatory disease of the upper airways. , 2000, American journal of respiratory and critical care medicine.

[44]  G. Hansson,et al.  Induction of CD36 by all-trans retinoic acid: retinoic acid receptor signaling in the pathogenesis of atherosclerosis. , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.